ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Ingenus Pharmaceuticals, LLC

Official 2024 U.S. DOL Form 5500 summary for Ingenus Pharmaceuticals, LLC (Ingenus Pharmaceuticals, LLC 401(k) Profit Sharing Plan · EIN 27-1195763 · PN 001): $20.51M net assets, 343 active participants, and $45.95 per $10,000 (45.95 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorIngenus Pharmaceuticals, LLC
Filing IdentifierIngenus Pharmaceuticals, LLC 401(k) Profit Sharing Plan · EIN 27-1195763 · PN 001
Plan Category & State401(k) Defined Contribution (FL)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$20.51M
Active Participants343
Direct Admin Fee Rate$45.95 per $10,000 (45.95 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI